Boots takeover bid sparks fears of repeat of Homebase retail disaster | UK | News

A failed Australian experiment on Britain’s high street has revived the specter of retail disaster in political and business circles as the threat of another major takeover from Down Under begins to gain momentum.
At the center of the renewed comparisons is Bunnings, Australia’s dominant warehouse-style DIY chain, which is trying to reshape the once well-known British retailer following a high-profile acquisition.
When it entered the UK with the £340m Homebase acquisition in 2017, the plan was to transplant its model wholesale to the UK market.
The strategy quickly ran into trouble.
It resolved completely within two years.
By 2018, Wesfarmers, the group behind Bunnings, had wiped out hundreds of millions of pounds and sold Homebase for just £1.
What appeared to be a simple underperforming chain from Australia turned out to be much more complex in Britain.
“Homebase was a very feminine DIY store,” senior retail analyst Clive Black said.
Rather than focusing on commerce-heavy DIY customers, Homebase has evolved into a softer, lifestyle-focused retailer selling home décor, furniture, garden products and house plants.
“These guys came in and tried to turn this place into a pushy, very male-oriented bench builder’s merchant,” Black said. “This was a complete and utter disaster.”
That experience is now being reconsidered as attention turns to another potential Australian bid for a major British retail brand, the Telegraph reports.
Sigma Healthcare, the group behind Australian-listed Chemist Warehouse, was revealed last week to be among those exploring a possible bid for the 177-year-old UK pharmacy chain Boots, valuing it at around £7.5bn.
Sigma’s growing interest in Boots comes as the Australian group steps up efforts to expand its footprint beyond its home market.
The company was formed through the merger of Chemist Warehouse and Sigma Healthcare, which was completed last year, creating an expanded pharmacy group operating under multiple retail brands in Australia and New Zealand.
One of the key forces behind its international progress is Mario Verrocchi, co-founder of Chemist Warehouse and one of Australia’s most influential figures in the pharmacy industry.
Verrocchi had previously made positive statements about Boots. In interviews with Australian Financial ReviewHe identified the UK chain as an early influence on the development of Chemist Warehouse and has consistently highlighted Britain’s pharmacy market as an area of long-term interest.
The group has made a small foray into the UK through Green Light Pharmacy, a London-based chain that has begun transitioning to the Chemist Warehouse brand.
The acquisition of Boots would represent a much more significant step, but uncertainty remains over how Sigma will ultimately approach the business if a deal is completed.




